RARE Ultragenyx Pharmaceutical Inc. - Common Stock

NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗

$26,56

Prezzo · Ago 20, 2026

Fondamentali al Ago 5, 2026

Margine di Profitto Netto

-85.4%

RARE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$26.56

Capitalizzazione di Mercato

$2.61B

P/E (TTM)

-4.6

EPS (TTM)

$-5.83

Ricavi (TTM)

$673M

Rendimento div.

—

ROE

-1613.2%

D/E Debito/Patrimonio

—

Intervallo 52 sett.

$18 – $40

RARE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $673M

2016-12-31 → 2025-12-31

EPS $-5.83

2020-12-31 → 2025-12-31

Flusso di cassa libero $-472M

2016-12-31 → 2025-12-31

Margini -85.4%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

P/E (TTM)

-4.6

97.6

P/S (TTM)

3.9

7.7

P/B

-32.6

8.0

Price / FCF (Prezzo / FCF)

-5.5

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

Operating Margin (Margine Operativo)

-79.5%

—

Net Profit Margin (Margine di Profitto Netto)

-85.4%

-51.7%

ROA

-37.9%

-44.2%

ROE

-1613.2%

-63.5%

ROIC

673.4%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

Current Ratio (Rapporto corrente)

2.5

4.9

Quick Ratio

1.5

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

Revenue YoY (Ricavi YoY)

20.2%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

22.8%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

20.0%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-5.83

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

RARE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 25 analisti

Acquisto forte 8 32,0%
Compra 14 56,0%
Mantieni 3 12,0%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

19 analisti · 2026-08-15

Mediana $46.00

Media $52.84

← Sotto tutti i target $26.56

Basso $27.00

Alto $96.00

Target mediano $46.00 +73,2%

Target medio $52.84 +99,0%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

-0.08%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.90	$-1.24	0.34%
31 Marzo 2026	$-1.84	$-1.54	-0.30%
31 Dicembre 2025	$-1.29	$-1.11	-0.18%
30 Settembre 2025	$-1.81	$-1.26	-0.55%
30 Giugno 2025	$-1.17	$-1.32	0.15%
31 Marzo 2025	$-1.57	$-1.65	0.08%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
RARE	$2.22B	-3.9	20.2%	-85.4%	-1613.2%	—
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	—
NRIX	$1.80B	-5.8	53.9%	-314.9%	-53.6%	—
SLS	$577M	-15.1	—	—	-55.4%	—
PGEN	$1.48B	-3.1	146.7%	-2588.2%	3159.1%	—
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	—
KOD	$1.73B	-6.5	—	—	-202.0%	—
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	—
COAG	—	—	—	—	—	—
MLYS	$2.96B	-15.8	—	—	-32.2%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	$673M	$560M	$434M	$363M	$351M	$271M	$104M	$51M	$3M	$133.0K
Cost of Revenue	·	·	·	·	·	·	·	$1M	$1.0K	·
R&D Expense	$750M	$698M	$648M	$706M	$497M	$412M	$357M	$294M	$232M	$183M
SG&A Expense	$349M	$321M	$310M	$278M	$220M	$183M	$162M	$128M	$100M	$65M
Operating Expenses	·	·	·	·	·	$601M	$528M	$423M	$332M	$248M
Operating Income	$-535M	$-536M	$-569M	$-649M	$-382M	$-330M	$-424M	$-371M	$-329M	$-248M
Interest Income	$25M	$37M	$27M	$11M	$2M	$7M	$13M	$10M	$4M	$4M
Other Non-op	$1M	$-5M	$-1M	$-2M	$-2M	$607.0K	$-787.0K	$-6M	$7M	$-2M
Pretax Income	$-571M	$-567M	$-609M	$-702M	$-453M	$-185M	$-399M	$-197M	$-318M	$-246M
Income Tax	$4M	$2M	$-2M	$6M	$1M	$1M	$3M	$514.0K	$-16M	$35.0K
Net Income	$-575M	$-569M	$-607M	$-707M	$-454M	$-187M	$-403M	$-198M	$-302M	$-246M
EPS (Basic)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	·	·	·	·
EPS (Diluted)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	·	·	·	·
Shares (Basic)	98,600,000	90,500,000	73,500,000	69,914,225	67,795,540	60,845,550	·	·	·	·
Shares (Diluted)	98,600,000	90,500,000	73,500,000	69,914,225	67,795,540	60,845,550	·	·	·	·
EBITDA	$-500M	$-500M	$-543M	$-631M	$-368M	$-318M	$-416M	$-352M	$-323M	$-245M

Stato Patrimoniale 29

Dati annuali Stato Patrimoniale per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	$421M	$174M	$214M	$133M	$308M	$714M	$434M	$113M	$100M	$161M
Short-term Investments	·	·	·	·	·	·	$322M	$346M	$134M	$219M
Receivables	$158M	$122M	$73M	$40M	$28M	$23M	$33M	$13M	$5M	·
Inventory	$52M	$45M	$34M	$27M	$16M	$13M	$12M	$7M	$757.0K	·
Prepaid Expense	$61M	$40M	$48M	$69M	$72M	$58M	$51M	$43M	$29M	$20M
Other Current Assets	·	·	$48M	$69M	·	·	·	·	·	·
Current Assets	$951M	$817M	$732M	$884M	$857M	$1.30B	$851M	$522M	$270M	$402M
PP&E (Net)	$244M	$266M	$291M	$260M	$141M	$74M	$44M	$20M	$22M	$17M
PP&E (Gross)	$380M	$378M	$374M	$323M	$191M	$111M	$70M	$38M	$33M	$23M
Accum. Depreciation	$136M	$112M	$83M	$63M	$50M	$37M	$26M	$18M	$11M	$6M
Goodwill	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	·
Intangibles	$176M	$178M	$166M	$160M	$131M	$131M	$129M	$129M	$142M	·
Other Non-current Assets	$60M	$63M	$58M	$48M	$21M	$9M	$3M	$4M	$3M	$2M
Total Assets	$1.53B	$1.50B	$1.49B	$1.55B	$1.52B	$1.76B	$1.14B	$720M	$491M	$541M
Accounts Payable	$31M	$39M	$42M	$43M	$17M	$13M	$13M	$12M	$9M	$5M
Accrued Liabilities	$265M	$241M	$196M	$205M	$146M	$108M	$83M	$62M	$62M	$55M
Current Liabilities	$384M	$344M	$280M	$261M	$181M	$190M	$103M	$75M	$71M	$60M
Capital Leases	$24M	$30M	$31M	$20M	$30M	$39M	$30M	·	·	·
Deferred Tax	$30M	$30M	$30M	$32M	$33M	$33M	$33M	$31M	$31M	·
Other Non-current Liabilities	$44M	$17M	$12M	$5M	$1M	$7M	·	$5M	$5M	$6M
Total Liabilities	$1.60B	$1.24B	$1.22B	$1.19B	$600M	$605M	$482M	$111M	$107M	$67M
Common Stock	$0	$0	$82.0K	$70.0K	$69.0K	$67.0K	$58.0K	$51.0K	$44.0K	$41.0K
Paid-in Capital	$4.45B	$4.21B	$3.66B	$3.14B	$3.00B	$2.77B	$2.09B	$1.64B	$1.22B	$1.00B
Retained Earnings	$-4.53B	$-3.96B	$-3.39B	$-2.78B	$-2.07B	$-1.62B	$-1.43B	$-1.03B	$-833M	$-531M
Treasury Stock	$8M	$4M	$432.0K	$0	·	·	·	·	·	·
AOCI	$1M	$-1M	$647.0K	$-7M	$-1M	$689.0K	$-147.0K	$-633.0K	$-6M	$905.0K
Stockholders' Equity	$-80M	$255M	$275M	$352M	$923M	$1.15B	$654M	$609M	$383M	$474M
Liabilities + Equity	$1.53B	$1.50B	$1.49B	$1.55B	$1.52B	$1.76B	$1.14B	$720M	$491M	$541M
Shares Outstanding	96,600,000	92,500,000	82,300,000	70,200,000	69,344,998	66,818,520	57,838,220	50,860,588	44,167,071	41,240,230

Flusso di cassa 13

Dati annuali Flusso di cassa per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
D&A	$35M	$36M	$26M	$18M	$13M	$12M	$9M	$20M	$6M	$3M
Stock-based Comp	·	·	·	·	·	·	·	·	$68M	$48M
Deferred Tax	·	$-1M	$-2M	$2M	·	·	$2M	·	$-16M	·
Other Non-cash	$74M	$118M	$104M	$310M	$102M	$42M	$47M	$-112M	$-9M	$33M
Operating Cash Flow	$-466M	$-414M	$-475M	$-380M	$-339M	$-132M	$-345M	$-291M	$-254M	$-161M
CapEx	$6M	$7M	$44M	$116M	$73M	$44M	$25M	$4M	$3M	$10M
Investing Cash Flow	$236M	$-18M	$168M	$-292M	$-195M	$-179M	$-13M	$-33M	$55M	$91M
Stock Issued	·	·	·	$0	$0	$436M	$330M	$271M	·	·
Net Stock Activity	·	·	·	$0	·	$436M	$330M	$271M	·	·
Financing Cash Flow	$478M	$399M	$388M	$501M	$119M	$600M	$679M	$337M	$136M	$139M
Net Change in Cash	$252M	$-35M	$81M	$-172M	$-417M	$290M	$321M	$12M	$-62M	$69M
Taxes Paid	$4M	·	·	·	·	·	·	·	·	·
Free Cash Flow	$-472M	$-422M	$-519M	$-497M	$-412M	$-176M	$-370M	$-295M	$-257M	$-171M

Redditività 7

Dati annuali Redditività per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Operating Margin	-79.5%	-95.7%	-131.1%	-178.6%	-108.6%	-121.8%	-409.0%	-721.2%	-12593.5%	-186471.4%
Net Margin	-85.4%	-101.6%	-139.7%	-194.7%	-129.2%	-68.8%	-388.3%	-383.8%	-11567.3%	-184867.7%
Pretax Margin	-84.8%	-101.3%	-140.1%	-193.1%	-128.9%	-68.4%	-385.1%	-382.8%	-12187.5%	-184841.4%
EBITDA Margin	-74.3%	-89.3%	-125.1%	-173.6%	-104.9%	-117.3%	-400.8%	-683.2%	-12370.5%	-183897.0%
ROA	-37.9%	-38.0%	-40.0%	-46.1%	-27.7%	-12.9%	-43.4%	-32.6%	-58.6%	-44.7%
ROE	-1613.2%	-189.1%	-395.0%	-172.3%	-48.9%	-20.5%	-58.3%	-31.1%	-70.5%	-48.9%
ROIC	673.4%	-210.5%	-206.1%	-185.6%	-41.5%	-28.8%	-65.4%	-61.2%	-81.4%	-52.3%

Liquidità e Solvibilità 2

Dati annuali Liquidità e Solvibilità per RARE
Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Current Ratio		2.5	2.4	2.6	3.4	4.7	6.8	8.2	7.0	3.8	6.7
Quick Ratio		1.5	0.9	1.0	0.7	1.9	3.9	7.6	6.3	3.4	6.3

Efficienza 3

Dati annuali Efficienza per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Asset Turnover	0.4	0.4	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.0
Inventory Turnover	·	·	·	·	·	·	·	0.3	0.0	·
Receivables Turnover	4.8	5.7	7.6	10.6	13.6	9.7	4.6	5.7	1.0	·

Per Azione 5

Dati annuali Per Azione per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Book Value / Share	$-0.83	$2.76	$3.35	$5.02	$13.30	$17.28	$11.30	$11.97	$8.68	$11.49
Revenue / Share	$6.83	$6.19	$5.90	$5.20	·	·	·	·	·	·
Cash Flow / Share	$-4.73	$-4.57	$-6.46	$-5.44	·	·	·	·	·	·
Cash / Share	$4.36	$1.88	$2.59	$1.89	$4.44	$10.68	$7.50	$2.23	$2.28	$3.91
EPS (TTM)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	$-7.01	$-3.91	·	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue YoY	20.2%	29.0%	19.4%	3.4%	29.7%	·	·	·	·	·
Revenue CAGR 3Y	22.8%	16.8%	17.0%	·	·	·	·	·	·	·
Revenue CAGR 5Y	20.0%	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 10

Dati annuali Valutazione (TTM) per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue TTM	$673M	$560M	$434M	$363M	$351M	$271M	$104M	$51M	$3M	$133.0K
Net Income TTM	$-575M	$-569M	$-607M	$-707M	$-454M	$-187M	$-403M	$-198M	$-302M	$-246M
Market Cap	$2.22B	$3.89B	$3.94B	$3.25B	$5.83B	$9.25B	$2.47B	$2.21B	$2.05B	$2.90B
P/E	-3.9	-6.7	-5.8	-4.6	-12.6	-45.1	-6.1	-11.1	·	·
P/S	3.3	6.9	9.1	9.0	16.6	34.1	23.8	42.9	784.3	21801.5
P/B	-27.8	15.2	14.3	9.2	6.3	8.0	3.8	3.6	5.3	6.1
P / Tangible Book	·	117.9	61.2	22.1	7.8	9.4	·	·	·	·
P / Cash Flow	-4.8	-9.4	-8.3	-8.5	-17.2	-70.0	-7.2	-7.6	-8.1	-18.0
P / FCF	-4.7	-9.2	-7.6	-6.5	-14.2	-52.5	-6.7	-7.5	-8.0	-16.9
Earnings Yield	-25.4%	-14.9%	-17.2%	-21.8%	-8.0%	-2.2%	-16.4%	-9.0%	·	·

Conto Economico 14

Dati trimestrali Conto Economico per RARE
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$214M	$136M	$207M	$160M	$167M	$139M	$165M	$139M	$147M	$109M	$127M	$98M	$108M	$100M	$103M	$91M
R&D Expense	$167M	$187M	$203M	$216M	$165M	$166M	$188M	$170M	$162M	$178M	$160M	$157M	$165M	$166M	$171M	$237M
SG&A Expense	$88M	$88M	$88M	$87M	$87M	$87M	$82M	$80M	$81M	$78M	$77M	$75M	$81M	$77M	$73M	$70M
Operating Income	$-75M	$-169M	$-113M	$-171M	$-108M	$-143M	$-122M	$-132M	$-116M	$-165M	$-122M	$-145M	$-148M	$-154M	$-146M	$-225M
Interest Income	$5M	$6M	$7M	$6M	$6M	$7M	$10M	$11M	$7M	$9M	$9M	$6M	$6M	$6M	$6M	$3M
Other Non-op	$1M	·	$-934.0K	$-1M	$2M	$837.0K	$-5M	$3M	$-2M	$-2M	$1M	$-699.0K	$-2M	$308.0K	$180.0K	$-1M
Pretax Income	$-91M	$-184M	$-128M	$-180M	$-114M	$-150M	$-133M	$-133M	$-131M	$-170M	$-127M	$-159M	$-159M	$-163M	$-153M	$-239M
Income Tax	$1M	$1M	$870.0K	$873.0K	$1M	$1M	$384.0K	$303.0K	$858.0K	$455.0K	$-4M	$650.0K	$732.0K	$495.0K	$-1M	$6M
Net Income	$-92M	$-185M	$-129M	$-180M	$-115M	$-151M	$-133M	$-134M	$-132M	$-171M	$-124M	$-160M	$-160M	$-164M	$-152M	$-245M
EPS (Basic)	$-0.90	$-1.84	$-1.28	$-1.81	$-1.17	$-1.57	$-1.34	$-1.40	$-1.52	$-2.03	$-1.44	$-2.23	$-2.25	$-2.33	$-2.17	$-3.50
EPS (Diluted)	$-0.90	$-1.84	$-1.28	$-1.81	$-1.17	$-1.57	$-1.34	$-1.40	$-1.52	$-2.03	$-1.44	$-2.23	$-2.25	$-2.33	$-2.17	$-3.50
Shares (Basic)	101,900,000	100,600,000	-195,920,392	99,771,297	98,500,000	96,300,000	-175,860,804	95,493,996	86,580,516	84,286,292	-139,430,962	71,664,493	70,897,991	70,368,478	-139,581,974	70,054,173
Shares (Diluted)	101,900,000	100,600,000	-195,920,392	99,771,297	98,500,000	96,300,000	-175,860,804	95,493,996	86,580,516	84,286,292	-139,430,962	71,664,493	70,897,991	70,368,478	-139,581,974	70,054,173
EBITDA	$-75M	$-161M	·	$-171M	$-108M	$-134M	·	$-132M	$-116M	$-157M	·	$-145M	$-148M	$-149M	·	$-225M

Stato Patrimoniale 28

Dati trimestrali Stato Patrimoniale per RARE
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$125M	$175M	$421M	$203M	$176M	$127M	$174M	$151M	$481M	$112M	$214M	$73M	$102M	$86M	$133M	$392M
Receivables	$200M	$121M	$158M	$113M	$124M	$99M	$122M	$93M	$106M	$100M	·	$79M	$71M	$43M	·	$31M
Inventory	$59M	$55M	$52M	$52M	$46M	$46M	$45M	$43M	$40M	$36M	·	$32M	$28M	$27M	·	$22M
Prepaid Expense	$55M	$68M	$61M	$53M	$61M	$60M	$40M	·	·	·	·	$46M	$51M	$67M	·	$71M
Other Current Assets	·	·	·	·	·	·	·	$41M	$55M	$48M	·	·	·	·	·	·
Current Assets	$606M	$657M	$951M	$643M	$720M	$699M	$817M	$800M	$965M	$596M	·	$599M	$702M	$766M	·	$1.01B
PP&E (Net)	$235M	$239M	$244M	$250M	$256M	$261M	$266M	$272M	$279M	$285M	·	$297M	$289M	$278M	·	$235M
PP&E (Gross)	·	·	$380M	·	·	·	$378M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$136M	·	·	·	$112M	·	·	·	·	·	·	·	·	·
Goodwill	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	·	$44M	$44M	$44M	·	$44M
Intangibles	$172M	$174M	$176M	$173M	$175M	$177M	$178M	$165M	$166M	$165M	·	$157M	$158M	$159M	·	$158M
Other Non-current Assets	$63M	$61M	$60M	$58M	$60M	$62M	$63M	$54M	$54M	$60M	·	$28M	$26M	$22M	·	$18M
Total Assets	$1.26B	$1.30B	$1.53B	$1.19B	$1.31B	$1.31B	$1.50B	$1.54B	$1.62B	$1.31B	·	$1.24B	$1.31B	$1.38B	·	$1.62B
Accounts Payable	$39M	$42M	$31M	$41M	$34M	$47M	$39M	$36M	$60M	$41M	·	$33M	$42M	$59M	·	$24M
Accrued Liabilities	$221M	$194M	$265M	$221M	$181M	$173M	$241M	$185M	$154M	$149M	·	$179M	$168M	$144M	·	$189M
Current Liabilities	$351M	$325M	$384M	$340M	$293M	$292M	$344M	$285M	$273M	$246M	·	$254M	$244M	$218M	·	$227M
Capital Leases	·	·	$24M	$22M	$25M	$28M	$30M	·	·	·	·	·	·	·	·	·
Deferred Tax	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	·	$32M	$32M	$32M	·	$33M
Other Non-current Liabilities	$41M	$42M	$20M	$19M	$17M	$17M	$17M	$16M	$15M	$14M	·	$10M	$10M	$9M	·	$4M
Total Liabilities	$1.55B	$1.52B	$1.60B	$1.17B	$1.15B	$1.16B	$1.24B	$1.18B	$1.19B	$1.17B	·	$1.21B	$1.18B	$1.16B	·	$1.15B
Common Stock	$0	$0	$0	$96.0K	$96.0K	$94.0K	$0	$92.0K	$92.0K	$83.0K	·	$72.0K	$71.0K	$71.0K	·	$70.0K
Paid-in Capital	$4.52B	$4.48B	$4.45B	$4.41B	$4.37B	$4.25B	$4.21B	$4.17B	$4.12B	$3.70B	·	$3.30B	$3.24B	$3.17B	·	$3.11B
Retained Earnings	$-4.81B	$-4.72B	$-4.53B	$-4.40B	$-4.22B	$-4.11B	$-3.96B	$-3.82B	$-3.69B	$-3.56B	·	$-3.26B	$-3.10B	$-2.94B	·	$-2.63B
Treasury Stock	$10M	$10M	$8M	$8M	$8M	$8M	$4M	$4M	$3M	$3M	·	$381.0K	$381.0K	$356.0K	·	·
AOCI	$0	$0	$1M	$820.0K	$-268.0K	$-341.0K	$-1M	$896.0K	$-1M	$-431.0K	·	$-2M	$-3M	$-4M	·	$-10M
Stockholders' Equity	$-291M	$-236M	$-80M	$9M	$151M	$144M	$255M	$347M	$432M	$140M	$275M	$32M	$129M	$220M	$352M	$469M
Liabilities + Equity	$1.26B	$1.30B	$1.53B	$1.19B	$1.31B	$1.31B	$1.50B	$1.54B	$1.62B	$1.31B	·	$1.24B	$1.31B	$1.38B	·	$1.62B
Shares Outstanding	98,600,000	98,300,000	96,600,000	96,442,027	96,353,634	93,903,785	92,500,000	92,304,317	92,135,384	83,094,037	82,300,000	72,174,307	71,465,424	70,660,249	70,197,297	70,079,777

Flusso di cassa 8

Dati trimestrali Flusso di cassa per RARE
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$8M	$8M	$9M	$9M	$9M	$9M	$10M	$9M	$9M	$9M	$8M	$7M	$5M	$5M	$5M	$5M
Other Non-cash	·	$-20M	·	·	·	$-24M	·	·	·	$-29M	·	·	·	$2M	·	·
Operating Cash Flow	$-97M	$-197M	$-100M	$-91M	$-108M	$-166M	$-79M	$-67M	$-77M	$-191M	$-84M	$-118M	$-116M	$-157M	$-90M	$-95M
CapEx	$1M	$1M	$938.0K	$1M	$2M	$1M	$163.0K	$2M	$2M	$3M	$1M	$4M	$14M	$25M	$27M	$26M
Investing Cash Flow	$44M	$-49M	$-72M	$117M	$71M	$120M	$103M	$-276M	$61M	$94M	$-107M	$64M	$99M	$111M	$-172M	$-162M
Financing Cash Flow	·	·	$394M	$2.0K	$84M	$157.0K	$3M	$11M	$385M	$-58.0K	$330M	$25M	$33M	$-722.0K	$2M	$492M
Net Change in Cash	$-49M	$-247M	$221M	$26M	$49M	$-45M	$24M	$-330M	$368M	$-97M	$140M	$-29M	$16M	$-46M	$-259M	$234M
Free Cash Flow	·	$-198M	·	·	·	$-168M	·	·	·	$-194M	·	·	·	$-182M	·	·

Redditività 7

Dati trimestrali Redditività per RARE
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-35.0%	-124.3%	·	-106.8%	-64.8%	-102.6%	·	-94.6%	-79.1%	-151.9%	·	-148.0%	-136.6%	-153.3%	·	-248.1%
Net Margin	-43.0%	-136.0%	·	-112.8%	-69.0%	-108.5%	·	-95.7%	-89.5%	-156.8%	·	-162.8%	-147.6%	-163.2%	·	-270.2%
Pretax Margin	-42.5%	-135.3%	·	-112.3%	-68.5%	-107.5%	·	-95.5%	-88.9%	-156.4%	·	-162.2%	-146.9%	-162.7%	·	-263.3%
EBITDA Margin	-35.0%	-118.4%	·	-106.8%	-64.8%	-96.2%	·	-94.6%	-79.1%	-143.8%	·	-148.0%	-136.6%	-148.1%	·	-248.1%
ROA	-7.2%	-14.2%	·	-13.2%	-7.9%	-11.5%	·	-9.6%	-9.0%	-12.7%	·	-11.2%	-12.2%	-11.8%	·	-15.8%
ROE	131.7%	403.2%	·	-101.4%	-39.4%	-106.2%	·	-70.5%	-46.9%	-94.6%	·	-63.8%	-39.6%	-32.2%	·	-34.9%
ROIC	26.1%	72.0%	·	-1874.9%	-71.9%	-100.0%	·	-38.1%	-27.1%	-118.2%	·	-459.4%	-115.2%	-70.1%	·	-49.3%

Liquidità e Solvibilità 2

Dati trimestrali Liquidità e Solvibilità per RARE
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		1.7	2.0	·	1.9	2.5	2.4	·	2.8	3.5	2.4	·	2.4	2.9	3.5	·	4.5
Quick Ratio		0.9	0.9	·	0.9	1.0	0.8	·	0.9	2.1	0.9	·	0.6	0.7	0.6	·	1.9

Efficienza 2

Dati trimestrali Efficienza per RARE
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.2	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Receivables Turnover		1.3	1.2	·	1.6	1.4	1.4	·	1.6	1.7	1.5	·	1.8	2.0	2.8	·	3.2

Per Azione 5

Dati trimestrali Per Azione per RARE
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-2.95	$-2.40	·	$0.10	$1.57	$1.54	·	$3.76	$4.69	$1.69	·	$0.44	$1.81	$3.12	·	$6.69
Revenue / Share	$2.10	$1.35	·	$1.60	$1.69	$1.45	·	$1.46	$1.70	$1.29	·	$1.37	$1.53	$1.43	·	$1.29
Cash Flow / Share	·	$-1.96	·	·	·	$-1.73	·	·	·	$-2.26	·	·	·	$-2.23	·	·
Cash / Share	$1.27	$1.78	·	$2.10	$1.83	$1.35	·	$1.63	$5.22	$1.35	·	$1.01	$1.43	$1.21	·	$5.59
EPS (TTM)	$-5.72	$-6.39	·	$-5.95	$-5.66	$-6.52	·	$-7.18	$-8.03	$-8.84	·	$-10.31	$-10.34	$-10.28	·	$-9.03

Valutazione (TTM) 10

Dati trimestrali Valutazione (TTM) per RARE
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$677M	$601M	·	$605M	$592M	$535M	·	$493M	$462M	$416M	·	$398M	$389M	$360M	·	$342M
Net Income TTM	$-572M	$-631M	·	$-580M	$-531M	$-587M	·	$-595M	$-622M	$-654M	·	$-729M	$-727M	$-720M	·	$-629M
Market Cap	$3.29B	$2.06B	·	$2.90B	$3.50B	$3.40B	·	$5.13B	$3.79B	$3.88B	·	$2.57B	$3.30B	$2.83B	·	$2.90B
P/E	-5.8	-3.3	·	-5.1	-6.4	-5.6	·	-7.7	-5.1	-5.3	·	-3.5	-4.5	-3.9	·	-4.6
P/S	4.9	3.4	·	4.8	5.9	6.4	·	10.4	8.2	9.3	·	6.5	8.5	7.9	·	8.5
P/B	-11.3	-8.7	·	316.7	23.2	23.6	·	14.8	8.8	27.7	·	81.1	25.5	12.9	·	6.2
P / Tangible Book	·	·	·	·	·	·	·	37.3	17.1	·	·	·	·	167.6	·	10.9
P / Cash Flow	·	-10.5	·	·	·	-20.4	·	·	·	-20.3	·	·	·	-18.1	·	·
P / FCF	·	-10.4	·	·	·	-20.3	·	·	·	-20.0	·	·	·	-15.6	·	·
Earnings Yield	-17.1%	-30.5%	·	-19.8%	-15.6%	-18.0%	·	-12.9%	-19.5%	-18.9%	·	-28.9%	-22.4%	-25.6%	·	-21.8%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$673M	$560M	$434M	$363M	$351M
Margine Operativo %	-79.5%	-95.7%	-131.1%	-178.6%	-108.6%
Utile netto	$-575M	$-569M	$-607M	$-707M	$-454M
EPS Diluito	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	2.5	2.4	2.6	3.4	4.7
Quick Ratio	1.5	0.9	1.0	0.7	1.9

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-472M	$-422M	$-519M	$-497M	$-412M

Ultime notizie Notizie recenti che menzionano questa società

Here is Why Ultragenyx Pharmaceutical (RARE) is One of the Best Buy-the-Dip Stocks Yahoo Finance · 2 mesi fa
La FDA Accetta la BLA di Ultragenyx (RARE) per la Terapia Genica UX111 per la Sindrome di Sanfilippo Yahoo Finance · 4 mesi fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 347 filer · $2.7B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
63 (-1 vs trimestre precedente)	37 (-8 vs trimestre precedente)	118 (-8 vs trimestre precedente)	98 (+11 vs trimestre precedente)	-486K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
RTW INVESTMENTS, LP	$260.338.324	7.796.895	9,48%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$226.722.608	6.790.135	8,26%	Azioni
STATE STREET CORP	$205.641.197	6.158.766	7,49%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$143.459.834	4.296.491	5,22%	Azioni
TWO SIGMA INVESTMENTS, LP	$120.911.868	3.621.200	4,40%	Azioni
SANDS CAPITAL MANAGEMENT, LLC	$105.457.908	3.158.368	3,84%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$98.157.217	2.939.719	3,57%	Azioni
FRONTIER CAPITAL MANAGEMENT CO LLC	$95.092.590	2.847.936	3,46%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$73.869.758	2.211.828	2,69%	Azioni
Bellevue Group AG	$66.204.857	1.982.775	2,41%	Azioni
Sofinnova Investments, Inc.	$57.347.492	1.717.505	2,09%	Azioni
D. E. Shaw & Co., Inc.	$54.716.761	1.638.717	1,99%	Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C.	$52.756.200	1.580.000	1,92%	Azioni
MPM BIOIMPACT LLC	$47.354.199	1.418.215	1,72%	Azioni
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$41.455.555	1.241.556	1,51%	Azioni
Candriam S.C.A.	$33.419.286	1.001.841	1,22%	Azioni
Rock Springs Capital Management LP	$32.316.678	967.855	1,18%	Azioni
Jefferies Financial Group Inc.	$31.040.212	929.626	1,13%	Azioni
Eagle Health Investments LP	$29.520.800	884.121	1,07%	Azioni
Qube Research & Technologies Ltd	$29.457.292	882.219	1,07%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$27.926.528	836.374	1,02%	Azioni
MILLENNIUM MANAGEMENT LLC	$25.403.947	760.825	0,92%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$25.377.702	760.039	0,92%	Azioni
Caption Management, LLC	$24.000.732	718.800	0,87%	Opzione Put
BANK OF AMERICA CORP /DE/	$23.505.893	703.980	0,86%	Azioni
Pictet Asset Management Holding SA	$23.159.948	753.695	0,84%	Azioni
VANGUARD FIDUCIARY TRUST CO	$22.418.413	671.411	0,82%	Azioni
GREAT POINT PARTNERS LLC	$20.034.000	600.000	0,73%	Opzione Put
Palo Alto Investors LP	$19.916.968	596.495	0,73%	Azioni
SPHERA FUNDS MANAGEMENT LTD.	$19.649.815	588.494	0,72%	Azioni
PANAGORA ASSET MANAGEMENT INC	$19.574.220	586.230	0,71%	Azioni
Trexquant Investment LP	$18.577.695	556.385	0,68%	Azioni
BlackRock, Inc.	$18.510.448	554.371	0,67%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$16.995.510	509.000	0,62%	Opzione Put
Sofinnova Investments, Inc.	$16.695.000	500.000	0,61%	Opzione Call
BNP PARIBAS FINANCIAL MARKETS	$16.633.796	498.167	0,61%	Azioni
TORONTO DOMINION BANK	$13.856.850	415.000	0,50%	Azioni
VANGUARD GROUP INC	$13.818.814	600.818	0,50%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$13.813.443	413.700	0,50%	Azioni
Caption Management, LLC	$13.753.341	411.900	0,50%	Opzione Call
Cutter Capital Management, LP	$13.734.562	379.303	0,50%	Azioni
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$13.624.489	408.041	0,50%	Azioni
ALGERT GLOBAL LLC	$13.020.898	389.964	0,47%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$12.735.614	381.420	0,46%	Azioni
AXA Investment Managers S.A.	$12.549.316	417.198	0,46%	Azioni
SummitTX Capital, L.P.	$12.496.875	374.270	0,46%	Azioni
GOLDMAN SACHS GROUP INC	$12.394.401	371.201	0,45%	Azioni
Privium Fund Management B.V.	$11.312.532	338.800	0,41%	Azioni
Squarepoint Ops LLC	$11.298.108	338.368	0,41%	Azioni
Walleye Capital LLC	$11.180.775	334.854	0,41%	Azioni
TWO SIGMA ADVISERS, LP	$11.076.800	481.600	0,40%	Azioni
Catalio Capital Management, LP	$10.559.654	316.252	0,38%	Azioni
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$9.944.000	297.819	0,36%	Azioni
Ensign Peak Advisors, Inc	$9.710.413	290.818	0,35%	Azioni
GordonMD Global Investments LP	$9.653.082	289.101	0,35%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$9.215.640	276.000	0,34%	Opzione Call
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$8.929.454	267.429	0,33%	Azioni
FMR LLC	$8.597.725	257.494	0,31%	Azioni
Quantinno Capital Management LP	$8.363.060	250.466	0,30%	Azioni
JPMORGAN CHASE & CO	$7.279.842	232.755	0,27%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$7.212.140	215.997	0,26%	Azioni
WORLDQUANT MILLENNIUM ADVISORS LLC	$7.157.948	214.374	0,26%	Azioni
CITADEL ADVISORS LLC	$7.029.630	210.531	0,26%	Azioni
Ishara Investments LP	$6.844.950	205.000	0,25%	Azioni
Man Group plc	$6.508.245	194.916	0,24%	Azioni
FIFTH THIRD BANCORP	$6.452.150	193.236	0,23%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$6.396.789	191.578	0,23%	Azioni
Blue Owl Capital Holdings LP	$6.098.283	182.638	0,22%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$6.039.283	180.871	0,22%	Azioni
Woodline Partners LP	$5.736.569	171.805	0,21%	Azioni
Atom Investors LP	$5.735.434	171.771	0,21%	Azioni
Swiss National Bank	$5.597.900	167.652	0,20%	Azioni
Ikarian Capital, LLC	$5.529.952	165.617	0,20%	Azioni
Stonepine Capital Management, LLC	$5.500.000	200.000	0,20%	Opzione Call
SCHRODER INVESTMENT MANAGEMENT GROUP	$5.260.270	171.456	0,19%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$5.229.275	156.612	0,19%	Azioni
Cubist Systematic Strategies, LLC	$5.194.035	172.674	0,19%	Azioni
Eversept Partners, LP	$5.146.401	154.130	0,19%	Azioni
MARSHALL WACE, LLP	$5.053.810	151.357	0,18%	Azioni
Ghisallo Capital Management LLC	$5.008.500	150.000	0,18%	Azioni
Mariner, LLC	$4.887.301	146.400	0,18%	Azioni
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	$4.841.550	145.000	0,18%	Azioni
FRED ALGER MANAGEMENT, LLC	$4.779.945	143.155	0,17%	Azioni
Corient Private Wealth LP	$4.644.350	139.094	0,17%	Azioni
SR One Capital Management, LP	$4.599.573	137.753	0,17%	Azioni
B Group, Inc.	$4.507.650	135.000	0,16%	Azioni
PINNACLE ASSOCIATES LTD	$4.377.563	131.104	0,16%	Azioni
Caption Management, LLC	$4.340.700	130.000	0,16%	Azioni
MOORE CAPITAL MANAGEMENT, LP	$4.275.089	128.035	0,16%	Azioni
RHUMBLINE ADVISERS	$4.144.518	124.125	0,15%	Azioni
Apollon Wealth Management, LLC	$4.121.962	123.449	0,15%	Azioni
Odyssean, LLC	$4.076.485	122.087	0,15%	Azioni
Assenagon Asset Management S.A.	$4.035.649	120.864	0,15%	Azioni
EFG Asset Management (North America) Corp.	$3.848.509	127.985	0,14%	Azioni
BARCLAYS PLC	$3.742.919	112.097	0,14%	Azioni
IEQ CAPITAL, LLC	$3.540.194	106.026	0,13%	Azioni
Rafferty Asset Management, LLC	$3.394.260	101.655	0,12%	Azioni
Crestwood Advisors Group, LLC	$3.348.149	100.274	0,12%	Azioni
Tetragon Partners GP Ltd	$3.339.000	100.000	0,12%	Opzione Call
CITADEL ADVISORS LLC	$3.308.949	99.100	0,12%	Opzione Put

Insider aziendali 28 insider · 15 dirigenti · 11 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Emil D Kakkis	President & CEO	16 Aprile 2026 A	735.739	1	$-1.240.411
Howard Horn	Chief Financial Officer	03 Agosto 2026 S	96.295	12	$-1.332.021
Mardi Dier	CFO & Executive Vice President	14 Ottobre 2022 S	66.695	0	$0
Wladimir Hogenhuis	Chief Operating Officer	04 Ottobre 2019 F	18.703	0	$0
Karah Herdman Parschauer	EVP and Chief Legal Officer	03 Agosto 2026 S	92.562	5	$-487.890
Eric Crombez	EVP and Chief Medical Officer	05 Maggio 2026 S	111.189	2	$-168.847
Theodore Alan Huizenga	SVP, Chief Accounting Officer	22 Aprile 2026 A	68.911	4	$-44.636
Erik Harris	EVP & Chief Commercial Officer	16 Aprile 2026 A	118.410	1	$-240.289
John Richard Pinion	EVP, Chief Quality Operations Officer	16 Aprile 2026 A	133.142	1	$-228.661
Dennis Karl Huang	EVP, Chief Technical Operations Officer	16 Aprile 2026 A	147.845	0	$0
Thomas Richard Kassberg	CBO & EVP	03 Marzo 2025 F	264.730	0	$0
Camille L Bedrosian	EVP and Chief Medical Officer	01 Marzo 2023 S	46.720	0	$0
Shalini Sharp	EVP, Finance	14 Ottobre 2020 S	97.812	0	$0
Jayson Donald Alexander Dallas	EVP & Chief Commercial Officer	01 Giugno 2018 F	23.830	0	$0
Sunil Agarwal	Chief Medical Officer	21 Maggio 2015 A	29.400	0	$0
Corazon (Corsee) D. Sanders	Direttore	15 Giugno 2026 S	21.095	1	$-50.100
Deborah Dunsire	Direttore	14 Maggio 2026 A	38.566	0	$0
Daniel G Welch	Direttore	14 Maggio 2026 A	40.441	0	$0
Amrit Ray	Direttore	15 Maggio 2025 A	23.365	0	$0
Shehnaaz Suliman	Direttore	15 Maggio 2025 A	25.940	0	$0
Lars Ekman	Direttore	24 Giugno 2022 A	17.745	0	$0
William Aliski	Direttore	24 Giugno 2021 A	66.849	0	$0
Clay B Siegall	Direttore	10 Agosto 2020 M	2.550	0	$0
Eran Nadav	Direttore	10 Luglio 2014 A	—	0	$0
Marten Steen	Direttore	30 Gennaio 2014 A	—	0	$0
Matthew K Fust	—	14 Maggio 2026 A	33.696	0	$0
Michael Narachi	—	14 Maggio 2026 A	40.441	0	$0
FMR LLC	—	01 Agosto 2014 J	1.457.994	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 1 partecipazione

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Ultragenyx Pharmaceutical Inc.	06 Novembre 2020	—	Deposito iniziale	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 48 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
TMFS · RBB Fund, Inc.	3,03%	74.931 NS	31 Maggio 2026	N-PORT
GNOM · Global X Funds	2,25%	52.426 NS	31 Maggio 2026	N-PORT
HAPS · Harbor ETF Trust	1,31%	83.707 NS	30 Aprile 2026	N-PORT
BBP · ETFis Series Trust I	1,09%	26.120 NS	30 Aprile 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,85%	178.057 NS	30 Aprile 2026	N-PORT
MMLG · First Trust Exchange-Traded Fund VI…	0,36%	13.877 NS	31 Maggio 2026	N-PORT
ESSC · Strategy Shares	0,31%	3.204 NS	30 Aprile 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,17%	194.551 SH	19 Agosto 2026	Giornaliero
IBB · iShares Trust	0,17%	667.035 SH	19 Agosto 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,17%	5.454 SH	19 Agosto 2026	Giornaliero
FYC · First Trust Exchange-Traded AlphaDE…	0,13%	54.688 NS	30 Aprile 2026	N-PORT
BIB · ProShares Trust	0,12%	3.571 NS	31 Maggio 2026	N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,12%	34.325 NS	30 Aprile 2026	N-PORT
GINN · Goldman Sachs ETF Trust	0,11%	9.780 NS	31 Maggio 2026	N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS	0,11%	46.526 SH	19 Agosto 2026	Giornaliero
BKSE · BNY Mellon ETF Trust	0,10%	3.381 NS	30 Aprile 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,10%	556.246 SH	19 Agosto 2026	Giornaliero
VBK · VANGUARD INDEX FUNDS	0,09%	1.238.640 SH	19 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,09%	46.723 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	0,09%	493.218 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,08%	2.473.457 SH	19 Agosto 2026	Giornaliero
IWO · iShares Trust	0,07%	396.778 SH	19 Agosto 2026	Giornaliero
ESML · iShares Trust	0,05%	59.354 SH	19 Agosto 2026	Giornaliero
ISCV · iShares Trust	0,05%	14.131 SH	19 Agosto 2026	Giornaliero
SCHA · SCHWAB STRATEGIC TRUST	0,05%	463.045 NS	31 Maggio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,04%	1.127.405 SH	19 Agosto 2026	Giornaliero
VB · VANGUARD INDEX FUNDS	0,04%	2.146.622 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,04%	251.571 SH	19 Agosto 2026	Giornaliero
ISCB · iShares Trust	0,04%	4.391 SH	19 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,03%	39.736 NS	30 Aprile 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,03%	5.097 NS	30 Aprile 2026	N-PORT
ISCG · iShares Trust	0,03%	10.374 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,02%	4.961 SH	19 Agosto 2026	Giornaliero
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	3.648 NS	31 Maggio 2026	N-PORT
ESGV · VANGUARD WORLD FUND	0,01%	21.519 SH	19 Agosto 2026	Giornaliero
GGUS · Goldman Sachs ETF Trust	0,01%	1.628 NS	31 Maggio 2026	N-PORT
ONEQ · Fidelity Commonwealth Trust	0,01%	32.531 NS	31 Maggio 2026	N-PORT
ITOT · iShares Trust	0,00%	140.889 SH	19 Agosto 2026	Giornaliero
TILT · FlexShares Trust	0,00%	3.080 NS	30 Aprile 2026	N-PORT
JUST · Goldman Sachs ETF Trust	0,00%	859 NS	31 Maggio 2026	N-PORT
RECS · Columbia ETF Trust I	0,00%	7.427 NS	30 Aprile 2026	N-PORT
IWV · iShares Trust	0,00%	25.586 SH	19 Agosto 2026	Giornaliero
SCHB · SCHWAB STRATEGIC TRUST	0,00%	56.898 NS	31 Maggio 2026	N-PORT
MSLC · MORGAN STANLEY PATHWAY FUNDS	0,00%	3.007 NS	31 Maggio 2026	N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST	0,00%	129 NS	31 Maggio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	2.987.783 SH	19 Agosto 2026	Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,00%	76.072 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	8.035 SH	19 Agosto 2026	Giornaliero

RARE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

RARE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

RARE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 347 filer · $2.7B totale · Aggiornato al 30 Giugno 2026

Insider aziendali 28 insider · 15 dirigenti · 11 direttori

Attivisti e proprietari del 5%+ 1 partecipazione

Proprietà ETF Posseduti da 48 ETF